DSpace Repository

Teplizumab approval for type 1 diabetes in the USA.

Show simple item record

dc.contributor.author Beran, David
dc.contributor.author Abidha, Carol
dc.contributor.author Adler, Amanda
dc.contributor.author de Beaufort, Carine
dc.contributor.author Lepeska, Molly
dc.contributor.author Levitt, Naomi
dc.contributor.author Pfiester, Elizabeth
dc.contributor.author Zafra Tanaka, Jessica Hanae
dc.contributor.author Gale, Edwin Am
dc.date.accessioned 2023-02-20T13:28:11Z
dc.date.available 2023-02-20T13:28:11Z
dc.date.issued 2023
dc.identifier.uri https://hdl.handle.net/20.500.12866/13159
dc.description.abstract The US Food and Drug Administration's (FDA) approval of teplizumab to delay the onset of type 1 diabetes could be seen as symbolic, because it came a century after the first use of insulin. Teplizumab, an anti-CD3 monoclonal antibody, is now approved in the USA for people at high risk of type 1 diabetes. This approval is a highly welcome development for this population and all those involved in the care and wellbeing of people with type 1 diabetes. However, in our opinion, the approval of teplizumab should be interpreted with caution. A global health perspective must consider evidence, cost, patient preferences, and equity... en_US
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartofseries Lancet. Diabetes and Endocrinology
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Teplizumab en_US
dc.subject type 1 diabetes en_US
dc.subject USA en_US
dc.subject.mesh Diabetes Mellitus, Type 1
dc.subject.mesh United States
dc.title Teplizumab approval for type 1 diabetes in the USA. en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1016/S2213-8587(22)00384-9
dc.relation.issn 2213-8595

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


My Account